Agoracom Blog Home

Posts Tagged ‘stocks’

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 9:57 AM on Monday, September 21st, 2020

SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.

Red-Light-Holland-Square

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17

  • Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
  • The company offered 0.8 million more ADSs than anticipated
  • At pricing, the company raised 27% more in proceeds than expected

Contributor: Renaissance Capital

COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.

COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.

The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.

The article Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 originally appeared on IPO investment manager Renaissance Capital’s web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO)Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source: https://www.nasdaq.com/articles/can-magic-mushrooms-treat-depression-biotech-compass-pathways-prices-upsized-us-ipo-above

Vegaste Technologies Corp. $VEGA.ca launches PlantX.ca to better serve the Canadian market $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 9:32 AM on Monday, September 21st, 2020
PlantX | LinkedIn
  • Company has launched its new domain www.PlantX.ca to better serve the Canadian market
  • New .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform

VANCOUVER,  BC, Sept. 21, 2020 – Vegaste Technologies Corp. (the ” Company ” or ” Vegaste “) (CSE: VEGA ), is pleased to announce that the Company has launched its new domain www.PlantX.ca to better serve the Canadian market.

The new .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform.

The new domain www.PlantX.ca will feature a growing list of partnerships with Canadian companies including Vita Life Fresh Market and UpMeals to offer plant-based vitamins, supplements, groceries, PlantX-branded water and plant-based meals made by LA-based chef Gregg Drusinsky . In addition to its e-commerce functionality, the site will offer Canadian consumers weekly updated plant-based recipes, restaurant resources and connects like-minded users in a community forum.

“Having a “.ca” domain is very exciting for us as a Canadian-based company,” said Sean Dollinger , PlantX founder “We plan to use this as an example of what we can do around the world as we expand, continue making new partnerships, and offer the best products and experience in every market.”

“At PlantX we’ve built our online platform with a different set of inventory, shipping logistics, payment processors, and other logistics separated by region,” says Alexandra Hoffman , PlantX Chief Marketing Officer. “Dividing the company traffic among different domains makes the company’s regional logistics systems better. I work very close with our development team, and it’s so exciting to see how quickly we can deploy sites for new locations.”

Since its inception in October, 2019, the Company’s PlantX platform has quickly emerged as an industry leader. As the fledgling plant-based sector continues its explosive growth, the Company will be at the forefront by continually evolving and delivering new ways to expand PlantX. With its forward-looking, cutting edge approach, the Company will continue to secure significant partnerships across North America while exploring innovative ways to expand both its e-commerce capabilities and digital resources to help educate, inspire, and uplift consumers.

About Vegaste

As the digital face of the plant-based community, Vegaste’s PlantX platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company will offer customers across North America more than 10,000 plant-based products by the end of September. In addition to offering meal and indoor plant deliveries, Vegaste currently has plans underway to expand its product lines to include cosmetics, vitamins, clothing, and its own water brand — but the business is not limited to an e-commerce platform. Vegaste uses its digital platform to build a community of like-minded consumers and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. Vegaste eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

The Company’s lynchpin www.PlantX.com is the digital face of everything plant-based and fueled by the power of education and accessibility. For those who don’t have the time to cook their own healthy plant-based meals, Vegaste offers a wide array of pre-made meals curated by Executive Chefs and nutritionists. For those looking to learn how to cook their own plant-based meals, Vegaste offers regularly updated weekly recipes. Unlike other plant-based e-commerce companies, Vegaste has a large selection of indoor plants for sale. The site educates consumers on the benefits of a plant-based diet with a specialized blog, connects like-minded individuals with its forum, and provides resources for the best plant-based restaurants, pop-up retailers and products across Canada and the USA .

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to secure additional commercial partnerships across North America , the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

The Company website is http://investor.plantx.com/ .

SOURCE Vegaste Technologies Corp.

Datametrex $DM.ca Receives Third COVID-19 Order from TV Production Company

Posted by AGORACOM-JC at 9:19 AM on Monday, September 21st, 2020
Webinar logo
  • Announced that it has received a third Purchase Order for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
  • The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020
  • This production is scheduled to run for three (3) months, totalling $630,000.
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits

Toronto, Ontario–(September 21, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has received a third Purchase Order (“P.O.”) for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.

The miniseries is produced by Nickelodeon Productions and distributed by MTV Networks in the United States and YTV in Canada, a Corus Entertainment company. Nickelodeon, now in its 41st year, is the number one entertainment brand for kids. Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc.

The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020. This production is scheduled to run for three (3) months, totalling $630,000. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

As previously stated, Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide, including in Vancouver, which represents 37% of Canadian Productions. The surrounding areas of Vancouver had 46 productions filming, which does not include the TV commercial market. Each of the shows potentially had a minimum of 100 people in their film crew.1

The next largest film and television market is Ontario, which represents 34% of Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 Billion in production volume.

Additionally, with Canada having far fewer cases of COVID-19 than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming and an advocate for the film industry, with our testing kits, collection services and labs already set up.

“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new film business for COVID-19 screening business,” said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

MedX Health Corp. $MDX.ca Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 9:16 AM on Monday, September 21st, 2020
Home - MedX Health
  • Announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately
  • Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.

“Naman’s extensive background in healthcare and medical devices, along with his deep relationships will allow us to accelerate business development opportunities in the region,” said Mike Druhan, President of Dermatological Products & Services. “Chantal is an internationally recognized and respected leader in the dermatology and aesthetics spaces, bringing credibility to our offerings and putting an impressive opinion leader network at our disposal.”

Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.

“Helping patients access an e-consult on suspicious lesions or moles quickly and easily means better treatment and better outcomes,” noted Mr. Demaghlatrous. “There is already significant interest and traction across the region and I am expecting substantial growth over the next six to nine months.”

Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.

“I have been using this device in my clinic for several years and have caught multiple melanomas,” said Ms. Ward. “The device is easy to use and the ability to have a dermatologist provide a remote e-consult, within 72 hours, is critical. Early detection is the key to a successful patient outcome.”

“MedX is in full commercialization mode and Naman and Chantal are welcomed additions to our team. Recently, Damon Goodwin and Nick Hoffman have been announced to our senior management team and we are already feeling their impact. It is a satisfying to know that MedX can attract such seasoned professionals and I strongly believe that is because of the strength of our technology offering and the culture we have built,” further commented Mr. Druhan.

Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005178/en/

Contacts:

Mike Druhan, President, Dermatological Services
MedX Health Corp
Tel: 905-599-7852

VIDEO – $HPQ.ca Silicon Development Agreement With #Apollon Solar Expands Into Producing HYDROGEN, With Samples To French Military By December $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 3:39 PM on Friday, September 18th, 2020

When a CEO puts this quote in a press release, you have to take it seriously, especially when his two technology partners helping deliver on it are world renowned:

“Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.

HYDROGEN BY HYDROLYSIS

Two technologies that could deliver vehicles with zero emissions are battery-electric powertrains and hydrogen fuel cells. HPQ is already on the road to becoming an electric battery player, with 2 NDA’s signed in the space – and now will be ready to start sending samples of its nano silicon powders to manufacture Hydrogen by hydrolysis, which is: 

“Getting porous silicon nano powders to react with water “H2O” and thereby releasing significant quantities of Hydrogen ” H2  “.

For decades, hydrogen was presumed to be “the fuel of the future,” with electric cars limited to the niche of small, short-range urban cars – but hasn’t been able to deliver due to too many issues to mention here with fuel cells.  Hydrogen by Hydrolysis is a great alternative but cost prohibitive due to the costs of porous silicon nano powders + power generation inefficiencies …. until now.

Enter HPQ Silicon.  

HPQ Silicon is so confident it can solve this problem that it will have samples of its powders ready for delivery to Apollon Solar and the French Military for testing by December.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: Else Nutrition $BABY.ca The Award Winning, Plant-Based Nutrition Company For Small Cap Investors $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:54 PM on Thursday, September 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

(TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL)

A Game Changer In Plant-Based Nutrition

Highlights

  • $CAD 18M bought deal financing + $CAD 6M private placement
  • US distribution agreement signed
  • Full-scale marketing campaign launched
  • Backed by A Billion Dollar Global Nutrition Company;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • USDA Organic Certification and multiple other key certifications.
  • Partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children
  • 7 Years of  R&D
  • Launched 1st Commercial Product Into US Market
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Right To Maintain 11.15% Ownership Through Future Financings

Watch Out Alec Baldwin, Hilaria’s Got a New Love 😉

https://youtube.com/watch?v=UBiYSt9Jekg

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

$HPQ.ca and Apollon Solar Extend Agreement to Work on Porous Silicon for Batteries and Expand Collaboration to Include Hydrogen Production $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 1:04 PM on Thursday, September 17th, 2020
  • Announced the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS in 2017
  • This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy

MONTREAL, Sept. 17, 2020 — HPQ Silicon Resources Inc. (“HPQ” or “ Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS (“Apollon”) in 2017.  This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy, mainly:

  1. Energy Storage development of a new generation of Lithium-ion batteries made using Porous Silicon manufactured by the transformation of HPQ PUREVAPTM Quartz Reduction Reactor “QRR” Silicon (Si) with Apollon patented process;

  2. Clean Renewable Hydrogen Production using Apollon Solar Gennao H2TM  200W, a fuel cell – based system that can produce hydrogen by hydrolysis simply by combining water with an environmentally friendly1 chemical powder.  Replacing the chemical powder presently used with nano silicon powders, such as those about to be produced by the HPQ NANO PUREVAPTM Nano Silicon Reactor (“NSiR”), could significantly increase the hydrogen generation capacity of the system.

“Since 2015, HPQ has been working on revolutionizing silicon manufacturing and its applications with the development of our PUREVAPTM technologies, scalable and extremely versatile processes that will allow the production of silicon materials perfectly suited to assist in the goals of decarbonization of the economy and the generation of green renewable energies” said Bernard Tourillon, President & CEO of HPQ Silicon Resources Inc.  “Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.”

APOLLON PROCESS: MAKING POROUS SILICON MANUFACTURING ECONOMICALLY VIABLE

Porous silicon is a Silicon (Si) structure in which Nanopores have been formed by electrochemical etching.  Addressable markets for porous silicon are substantial, but existing electrochemical etching processes require very pure Silicon (Si) feed stock (9N to 11N), making porous Silicon cost prohibitive.

To make affordable porous Silicon, Apollon developed and obtained a worldwide patent for an electrochemical etching process that can use (2N to 4N) Silicon (Si) to make porous Silicon wafers.

AIMING TO SEND POROUS SILICON NANOPOWDER SAMPLES TO END USERS BY DECEMBER 2020

Mindful of HPQ’s competitive advantage, the ability of PUREVAPTM QRR to produce 2N to 4N Silicon (Si) at the lowest cost in the industry, HPQ and Apollon are busy manufacturing samples of porous Si nanopowders of different sizes (2 nm to 1 µm) with porous structure sizes of either Microporous (<5nm), Mesoporous (5nm – 50nm) and Macroporous (>50nm).  The aim being to send samples, to end users’ specifications, by December 2020.  The extension of the agreement continues HPQ’s North American exclusivity over the use of Apollon’s patented process to manufacture Porous Silicon until at least December 31, 2020.

________________
1 Non-toxic and recyclable

HYDROLYSIS HYDROGEN PRODUCTION: APOLLON SOLAR’S GENNAO H2TM SYSTEM

Apollon Solar is also active in hydrogen based clean renewable energy.  Over the years, they have developed an expertise in hydrogen production by hydrolysis, getting porous silicon nano powders to react with water “H2O” and therewith releasing significant quantities of hydrogen “H2”.

Drawing on this unique expertise, Apollon was approached by the French government to develop a compact and portable hydrogen-based electricity generation system that must be reliable and efficient enough to charge military personnel batteries on missions.  This work led to the creation of the Gennao H2TM a self-contained system that integrates a fuel cell.  The system operation is simple; a chemical powder is introduced, and as the powder reacts with water, hydrogen is generated by hydrolysis and converted into electricity by the integrated fuel cell, thus allowing the system to charge several batteries at once.

The operational capabilities of the system having reached the validation phase of the French military program, Apollon Solar is now ready to start the commercialization of a civilian version of its GennaoTM H2 system.

COLLABORATION WITH HPQ SILICON TO CREATE MORE EFFICIENT AND ECONOMICAL HYDROGEN

With Apollon Solar’s Hydrogen business having entered the commercial phase, HPQ took advantage of the 5th renewal to include it in the scope of the agreement.

Even though using porous silicon nanopowders would double the amount of hydrogen released by the system, the high costs of making porous silicon nanopowders required Apollon to use a less efficient, but more economical and environmentally friendly chemical powder to launch its GennaoTM H2 system.

With a goal of increasing the efficiency of the system, HPQ and Apollon will explore the technical and commercial potential of creating a new generation of more efficient, economical and environmentally friendly powders for the GennaoTM system using either:

  1. Silicon nanopowders made by HPQ’s PUREVAPTM Nano Silicon Reactor to increase the H2 generation potential of the GennaoTM H2 system by 40% (based on the mass capacity production of H2 of 14% of Silicon Nanopowders);
       a. By December 2020, HPQ-NANO plans to send Apollon the first samples of silicon nanopowders manufactured by PUREVAPTM NSiR for H2 generation testing;

  2. Porous silicon nanopowders manufactured with the transformation of Silicon produced by HPQ’s PUREVAPTM QRR process in Apollon’s patented process, to increase the H2 generation potential of the GennaoTM H2 system by 100% (based on the mass capacity production of H2 of 20% of Silicon Nanopowders);

Also included in the agreement is the right for HPQ to commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system, as well as, also distribute and sell the powders required for the hydrolysis production of Hydrogen (“H2”).

Apollon will support HPQ North American marketing of the GennaoTM H2 system and the powder bags.  By November 2020, Apollon will make available to HPQ a GennaoTM H2 system and the bags of powder needed for demonstration to potential buyers.

During the term of this fifth renewal, Apollon and HPQ will work to finalize a long-term commercial agreement that will grant HPQ (or one of its subsidiaries) a Canadian exclusivity for the sale of GennaoTM H2 system and associated powders bags, and the exclusivity for all customers located in the United States to whom HPQ is marketing GennaoTM H2 system.

Finally, the parties have agreed that during the renewal period, or until the date of the signing of a long-term commercial agreement, that HPQ will have Canadian exclusivity on the distribution, sale, marketing and representation of GennaoTM H2 system and associated powders, and that it will be able to distribute, sell, market and represent GennaoTM H2 system and associated powders with customers in the United States.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) and the decarbonization of the economy presently under way.  Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;

    — HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);

  • The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;

    — HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;

    — During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;

    — The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;

    — Develop the hydrogen generation potential of Silicon nanopowders for usage with the GennaoTM system;

    — Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Augmented Reality #AR and Virtual Reality #VR in Sports and Entertainment Market Will Reflect Significant Growth – SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 12:28 PM on Thursday, September 17th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida. The company also signed of a five year $250,000USD licensing agreement with WaV Sports & Entertainment for the launch of their new proprietary line of global sports engagement products. Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Augmented Reality and Virtual Reality in Sports and Entertainment Market Forecast to 2027 – Covid-19 Impact and Global Analysis

  • AR and VR are the technologies which immerse the user into virtual world and allows to interact with the virtual objects being in real environment
  • The new interface of communication offered by AR and VR technology will overtake the markets of existing interfaces in the gaming and entertainment activities

By:tip September 15, 2020

“Augmented Reality and Virtual Reality in Sports and Entertainment Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Smart phones are the must have digital devices today, they have changed the way we communicate, travel, design, run business and many more. In recent years smartphones revolutionized the world and still the ongoing R&Ds to launch advanced features, improved and more customer centric and enterprise level applications holds the market for years to go. AR and VR are the technologies which immerse the user into virtual world and allows to interact with the virtual objects being in real environment. The new interface of communication offered by AR and VR technology will overtake the markets of existing interfaces in the gaming and entertainment activities.

The global augmented reality and virtual reality in sports and entertainment market is segmented on the basis of software type and device. Based on software type, the augmented reality and virtual reality in sports and entertainment market is segmented into augmented reality software and virtual reality content creation. The augmented reality and virtual reality in sports and entertainment market on the basis of the device is classified into augmented reality head-mounted device and virtual reality head-mounted device. The report “Augmented Reality and Virtual Reality in Sports and Entertainment Market” gives varied description about the segmentation of the market on the basis of segmented software type, device and geography. And leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Typhoid Vaccines market.

Smartphone and tablets manufacturers are integrating more AR applications to increase the user experience and with growing smartphone market, AR integrations are expected to take a leap in near future which is anticipated to be the major driver for the augmented reality and virtual reality in sports and entertainment market. Lack of technological understanding and awareness about these products coupled with higher costs associated would pose a challenge to the growth of the augmented reality and virtual reality in sports and entertainment market. Huge investments towards technological advancements in the sports and entertainment sector would provide good opportunities to the players operating in the augmented reality and virtual reality in sports and entertainment market.

Source: https://www.kws24.com/augmented-reality-and-virtual-reality-in-sports-and-entertainment-market-will-reflect-significant-growth-in-future-artoolworks-blippar-eon-reality-google-htc-corporation-microsoft/

Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics $SHRM.ca $RVV.ca

Posted by AGORACOM at 9:14 AM on Thursday, September 17th, 2020
Red-Light-Holland-Square

Toronto, Ontario–(Newsfile Corp. – September 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that Red Light Holland’s Science and Innovation division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has joined the Medical Psychedelics Working Group (“MPWG“), a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners. MPWG’s aim is to create a rational and enlightened approach to psychedelic research and clinical treatment. MPWG will explore innovation within the psychedelic space with a specific focus on how psychedelics can be integrated into primary and secondary healthcare. The Company believes that evidence-based science, sharing data, and strong partnerships are keys to success for the psychedelic community.

“We are elated to join the most respected experts in the industry. To be able to have open communication with leading academics like Professor David Nutt, Dr. Robin Carhart-Harris and Dr. Jo Neill is a major development for Scarlette Lillie Science and Innovation. Access is key in life and having access to the top minds in this sector is something we are all very excited about,” said Red Light Holland CEO and Director, Todd Shapiro.

“When we were approached by Red Light Holland’s Scarlette Lillie Science and Innovation, we were more than happy to include them in this very important working group. We are grateful for their support and we recognize the Company’s genuine and authentic approach to helping make positive change in this world through psilocybin research, education and information. We are thrilled to have Scarlette Lillie join our very MPWG,” stated Professor Jo Neill.

“Both Sarah Hashkes and I are pleased to be able to brainstorm and continue developing these important synergies with our peers in the field of Medical and Science Research to help elevate the Psychedelic Sector as a whole,” added Dr. Joe Geraci, Scarlette Lillie’s Scientific Advisor and CEO of Netramark.

About MPWG

MPWG is a working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

VIDEO – Empower Clinics $CBDT.ca Grows Revenues 130%, Patient Visits 125% And Becomes Cash Flow Positive $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:03 PM on Wednesday, September 16th, 2020

Sometimes, you just have to let the numbers speak for themselves.  With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for … but then these numbers came in for the first two quarters:

Revenues $USD 1.7M vs $745,000 = 130% Gain

Patient Visits 12,400 vs 5,500 = 125% Gain

CBDT has now delivered growth in 4 successive financial reports (Q4, FY 2019, Q1 and Q2), so it is safe to say that superstar CEO Steve McAuley can officially claim victory on the turnaround he inherited in 2019.

But he is far from done.

CBDT also just announced the potential acquisition of an 8,000 sq ft lab in Dallas (they do everything big over there) that can process 2,000 COVID-19 tests per 8 hour shift.  At an average price of ~ $USD 90 per test, the clinic could represent $USD 180,000 in revenue PER SHIFT.  However, until this acquisition closes, we’re not going to focus on it too much – but that could happen as early as next week.  

Moreover, CBDT has to actually fill that capacity, which McAuley says he is working on right now with some enterprise sized discussions taking place as we write. Can he pull it off?  First consider what he has already accomplished after inheriting a catastrophe of a company.  Secondly, McAuley, is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth … and gives us optimism about this acquisition.

Watch this amazing interview.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.